| (Values in U.S. Thousands) | Mar, 2017 | Dec, 2016 | Sep, 2016 | Jun, 2016 | Mar, 2016 |
| Sales | -9,999,000 | -9,999,000 | 21,810 | 22,210 | 20,240 |
| Sales Growth | unch | -45,945.94% | -1.80% | +9.73% | -0.05% |
| Net Income | -9,999,000 | -9,999,000 | -1,390 | 1,980 | -1,760 |
| Net Income Growth | unch | -719,253.04% | -170.20% | +212.50% | +80.97% |
Derma Sciences Cmn (DSCI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Derma Sciences, Inc. is engaged in the development, marketing and sales of proprietary and non-proprietary topical, nutrient-based wound care products for the management of certain chronic, non-healing skin ulcerations such as pressure and venous ulcers, surgical incisions and burns. (PRESS RELEASE)
Fiscal Year End Date: 12/31